The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?

A new immunotherapy drug used in a prostate cancer clinical trial is showing early promise in possible treatment of the disease.

Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons Prostate cancer (PCa) is the second most commonly diagnosed cancer in men with around ...

Former President Joe Biden was diagnosed last week with an aggressive form of prostate cancer that has spread to his bones. The news has raised lots of questions about the typically slow-growing ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

Paige, a digital pathology diagnostics company, has received De Novo marketing authorization from the Food and Drug Administration for its artificial intelligence software that helps detect prostate ...

Stereotactic intensity modulated radiotherapy after radical prostatectomy (SCIMITAR): Two-year quality of life and toxicity outcomes of a multicenter phase II trial. This is an ASCO Meeting Abstract ...

A 40-year-old dad received a shock cancer diagnosis after simply experiencing back pain, he is now raising awareness among ...

Credit: Getty Images Patients with de novo vs secondary metastatic hormone-sensitive prostate cancer were more likely to progression to castration-resistant disease, according to a real-world study. A ...